Burkitt lymphoma in children — what parents need to understand
If a doctor has mentioned Burkitt lymphoma, or childhood Burkitt, or a fast-growing lymphoma in your child, this page is for you. Burkitt lymphoma is rare, and its speed of growth is frightening — but it is also one of the most treatment-responsive lymphomas in paediatric oncology. At CION, every child's case is reviewed by a full tumour board before any treatment decision is made, and your 45-minute consultation gives us time to explain everything clearly.
- Burkitt lymphoma grows very fast — a lump that doubles in size over days should never wait for a routine appointment
- Three recognised forms exist — endemic (jaw-involving), sporadic (abdominal), and immunodeficiency-related; the sporadic form is most common in India
- Diagnosis requires a biopsy — imaging alone is not enough; accurate subtype confirmation guides the right treatment
- Free first consultation at CION — bring any existing scans or reports; our team will review them with you the same day
on Panel
Survival Rate*
Treated
(800+ reviews)
What is Burkitt lymphoma in a child?
Burkitt lymphoma is a cancer of the B-lymphocytes — white blood cells that normally form part of the immune system. It is classified as a high-grade non-Hodgkin lymphoma, meaning it arises from lymphoid tissue anywhere in the body rather than from the bone marrow directly. In children, the tumour most commonly appears in the abdomen, particularly around the intestines, kidneys, or ovaries. It can also involve lymph nodes in the neck, chest, or groin.
What makes Burkitt lymphoma different from other childhood lymphomas is its growth speed. A chromosomal change — specifically an abnormal rearrangement involving the MYC gene on chromosome 8 — causes B-lymphocytes to divide almost continuously. The tumour can visibly enlarge over a matter of days. This is alarming for any parent to witness, and it is one reason why getting to an experienced specialist quickly genuinely matters.
The three recognised forms of childhood Burkitt lymphoma — endemic, sporadic, and immunodeficiency-related — differ in where they start and in some risk factors, but all three respond to the same fundamental treatment approach: intensive short-course chemotherapy. The specific protocol and the number of treatment cycles depend on the stage and subtype identified at diagnosis.
Warning signs to watch for
The symptoms of a fast-growing lymphoma in a child can appear and worsen within just a few days. The signs most commonly reported by parents include:
- A firm, painless lump in the abdomen that was not there last week — or visible abdominal swelling
- Stomach pain, nausea, or vomiting with no other obvious cause
- Rapidly enlarging swelling in the jaw, cheek, or around the eye (more typical of the endemic subtype)
- Painless but rapidly enlarging lymph nodes in the neck, armpit, or groin
- Unexplained weight loss over a few weeks, with reduced appetite
- Night sweats that soak the bedclothes, or recurring fever without infection
- Difficulty breathing or a persistent cough if the chest is involved
Did you know?
Burkitt lymphoma has one of the shortest tumour doubling times of any human cancer — meaning the tumour can double in size in as little as 24 to 48 hours. This is directly linked to the MYC gene rearrangement at the heart of the disease. The same biology that makes Burkitt lymphoma grow so quickly also makes it highly sensitive to chemotherapy — intensive treatment can produce a rapid and dramatic reduction in tumour size. Prompt diagnosis and early referral to a specialist centre are therefore among the most important steps a parent can take.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You deserve unhurried answers — not a rushed ten-minute slot
Every CION consultation is 45 minutes. Every child's case goes to the tumour board. Decisions for healing, not billing.
Which type of Burkitt lymphoma does my child have?
The three recognised subtypes of childhood Burkitt lymphoma differ mainly in where they start and in certain associated risk factors. All three involve the same MYC gene abnormality. Your child's oncology team will confirm the subtype after reviewing the biopsy and molecular testing results.
Sporadic Burkitt Lymphoma
This is the form most often seen in children in India and across the world outside equatorial Africa. It typically starts in the abdomen — around the ileocaecal junction (where the small and large bowel meet), the kidneys, the ovaries, or elsewhere in the abdominal cavity. The presenting sign is usually a rapidly growing abdominal lump or generalised swelling of the belly, sometimes with nausea or vomiting. There is no established link with Epstein-Barr virus (EBV) in most sporadic cases.
Endemic Burkitt Lymphoma
Endemic Burkitt lymphoma is the form classically described in equatorial Africa and is strongly associated with Epstein-Barr virus (EBV) infection occurring in early childhood. It most commonly presents as a rapidly enlarging, painless swelling of the jaw or other facial bones. Orbital involvement causing eye protrusion can also occur. While less common in India, endemic-type presentations are occasionally seen, particularly in children who have had very early EBV infection. Treatment follows the same intensive chemotherapy framework used for sporadic disease.
Immunodeficiency-Related Burkitt Lymphoma
This subtype arises in children with a significantly weakened immune system — most commonly those living with HIV, or those who have received organ transplantation and are on immunosuppressive medicines. The underlying immune deficiency affects how aggressively the cancer behaves and what treatment the child can safely receive. Managing this form requires close collaboration between the oncology team and the team caring for the child's underlying condition. At CION, multidisciplinary tumour board review is the standard for every case — and is particularly important here.
How is Burkitt lymphoma diagnosed in a child?
Because Burkitt lymphoma grows so quickly, the diagnostic process is carried out urgently — typically within days, not weeks. Here is what to expect at each step.
Clinical assessment and blood tests
The first step is a thorough physical examination by an oncologist, who will measure any lumps, examine all lymph node regions, and assess the liver and spleen. Blood tests — including a complete blood count, liver and kidney function, uric acid, and LDH (lactate dehydrogenase) — help gauge the extent of disease and identify any immediate risks such as tumour lysis syndrome, a metabolic complication that can develop when the tumour begins breaking down.
Imaging to map the disease
An ultrasound is usually the first imaging test used to assess an abdominal lump. A CT scan of the chest, abdomen, and pelvis gives a more detailed picture of how far the lymphoma has spread, which lymph node groups are involved, and whether organs such as the kidneys or liver are affected. In selected cases, a PET scan may be used to check for disease elsewhere in the body. Imaging alone cannot confirm a Burkitt lymphoma diagnosis — a biopsy is always required.
Biopsy and pathology
A biopsy — removal of a small sample of tissue from the tumour or an affected lymph node — is the definitive diagnostic test. The pathologist examines the tissue under a microscope and looks for the characteristic features of Burkitt lymphoma, including a 'starry sky' appearance caused by scattered normal cells amid the dense lymphoma cells. Immunohistochemistry (IHC) confirms the B-cell origin. Fluorescence in situ hybridisation (FISH) testing is performed to detect the MYC gene rearrangement that confirms the diagnosis.
Bone marrow biopsy and lumbar puncture
Two additional procedures are routinely performed under sedation to complete the staging. A bone marrow biopsy checks whether lymphoma cells have reached the marrow — this changes the stage and the treatment intensity. A lumbar puncture collects a small amount of spinal fluid and checks whether lymphoma cells are present around the brain and spine, which is called CNS (central nervous system) involvement. Even if CNS involvement is not found, intrathecal chemotherapy — medicines given directly into the spinal fluid — is usually included in the treatment plan as a protective measure.
Tumour board review and treatment planning
Once all diagnostic results are available, the case is presented at a multidisciplinary tumour board — a meeting of medical oncologists, haematologists, paediatric oncology specialists, and radiologists. Together, the team assigns the disease stage, determines the risk group, and agrees on the treatment protocol. This is how care is delivered at CION for every child: no single doctor's decision, but a full team's consensus, documented and explained to you clearly before treatment begins.
Your child deserves care led by a team, not a single doctor
17 super-specialist oncologists. Tumour board for every case. 45-minute consultations where you can ask every question you need to ask.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Questions parents ask about Burkitt lymphoma in children
What is Burkitt lymphoma in a child?
Burkitt lymphoma is a cancer of the B-lymphocytes — a type of white blood cell that normally helps the body fight infections. In Burkitt lymphoma, a rearrangement of the MYC gene on chromosome 8 causes B-lymphocytes to multiply at an extremely rapid rate. It is categorised as a high-grade non-Hodgkin lymphoma and is one of the fastest-growing human tumours known. Despite this, childhood Burkitt lymphoma responds well to intensive chemotherapy, and most children with limited-stage disease achieve long-term remission when diagnosis and treatment begin promptly. At CION, every child's case is reviewed by a multidisciplinary tumour board — medical, surgical, and haematology oncologists together — before any treatment decision is made.
Why does Burkitt lymphoma grow so fast in children?
Burkitt lymphoma grows fast because of a chromosomal change that causes the MYC gene to become overactive. MYC is a gene that normally controls how quickly cells divide. When it is switched on permanently, lymphoma cells divide almost continuously — the doubling time can be as short as 24 to 48 hours. This is why a lump that appears suddenly and grows visibly over just a few days should always be evaluated promptly. The same biological feature that makes Burkitt lymphoma spread quickly also makes it highly sensitive to intensive chemotherapy, which is why rapid treatment can produce rapid response.
What are the warning signs of Burkitt lymphoma in children?
The signs depend on where the lymphoma starts. In the abdomen — the most common site in India — parents often notice a firm lump in the belly, abdominal swelling, or stomach pain that comes on over days rather than weeks. Some children develop nausea or vomiting because the tumour presses on the bowel. In the jaw or face (more typical of the endemic African form, but occasionally seen in Indian children), a rapidly enlarging, painless swelling of the jaw or cheek may appear. Swollen lymph nodes in the neck or groin, unexplained weight loss, night sweats, and persistent fever are also common warning signs. If any of these appear suddenly and worsen quickly, see a doctor promptly — do not wait for a routine appointment.
How is Burkitt lymphoma diagnosed?
Diagnosis begins with a blood test and imaging — typically an ultrasound or CT scan — to identify the location and extent of disease. The definitive diagnosis requires a biopsy: a small sample of lymph node or tumour tissue is taken and examined under a microscope by a pathologist. In Burkitt lymphoma, the pathologist looks for a classic 'starry sky' pattern of rapidly dividing cells. Immunohistochemistry and FISH (fluorescence in situ hybridisation) testing confirm the MYC gene rearrangement that characterises Burkitt lymphoma. A bone marrow biopsy and lumbar puncture are also done to check whether lymphoma cells have spread to the marrow or the fluid around the brain and spine. These steps together define the stage and guide the treatment plan.
How is Burkitt lymphoma treated in children?
Burkitt lymphoma in children is treated with intensive short-course chemotherapy regimens — typically over a period of weeks to a few months, rather than the longer protocols used for some other lymphomas. Treatment also includes chemotherapy given directly into the spinal fluid (intrathecal chemotherapy) to protect the central nervous system, because Burkitt lymphoma can involve or spread to the brain and spine. Surgery is rarely the main treatment; it may be used to obtain a biopsy or, occasionally, to remove a single confined tumour. Rituximab, a targeted immunotherapy agent, may be added in selected cases. Every child's treatment plan at CION is tailored by a tumour board — no two cases are identical, and the regimen depends on the stage, the specific subtype, and your child's overall health.
Is Burkitt lymphoma curable in children?
Burkitt lymphoma in children is one of the most chemotherapy-responsive cancers in paediatric oncology. Many children with limited-stage disease achieve long-term remission with treatment. Advanced-stage disease requires more intensive therapy but can still respond well when managed by an experienced specialist team. We cannot promise outcomes for any individual child — every case is different — but we can tell you that prompt diagnosis, the right chemotherapy protocol, and close monitoring throughout treatment all make a meaningful difference. At CION, the tumour board reviews every case and every response assessment together, so no decision depends on a single doctor's opinion alone.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.